National Institute of Allergy and Infectious Diseases
  National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Tuberculosis
 What is TB?
 TB Basics
 Research
  Research Goals
  NIAID Labs
  Networks, Consortia, and Partners
  Resources
  Research Training
  Meeting Summaries
  Publications
  Feature Stories
   Introduction to TB
   TB in History
   About the TB Bug
   Understanding TB
   Diagnosing TB
   Treating TB
   Preventing TB
   Global Problem


Tuberculosis (TB)

Deciphering the TB Bacterium Genome

Schematic of the TB bacterium's genome

Schematic of the TB bacterium's genome
Credit: The Institute for Genomic Research

Tuberculosis isn't like a lot of other infectious diseases because Mycobacterium tuberculosis (M. tb) isn't like a lot of other microbes. In contrast to the mad dash of growth characteristic of many infectious agents, M. tb moves at a microbial snail's pace. It takes a full day for M. tb to complete a round of cell division and two weeks of careful tending are required to grow visible quantities in the lab. This deliberate pace is matched by the slow progress of the disease. Frequently, active TB does not emerge until decades after the initial infection—and the majority of infected individuals never develop the disease at all.

How does M. tb escape destruction by the immune system for so long? That question, and others related to details of M. tb's behavior in the human body, became a bit easier to address when the entire sequence of M. tb's genome was published in 1998. Scientist Stewart Cole and others at the Sanger Center in England determined the order of every base pair in M. tb's ring-shaped chromosome. The well-characterized laboratory strain of M. tb sequenced by the British scientists has a staggering 4.4 million base pairs—making it one of the largest microbial genomes yet sequenced.

In 1996, as the Sanger Center project was getting underway, NIAID issued a grant to U.S.-based The Institute for Genomic Research (TIGR) to determine the sequence of a different strain of M. tb. This highly virulent strain first infected a children's clothing factory worker and was dubbed "Oshkosh."

The 4.4 million base pairs of M. tb's genome comprise about 4,000 genes. By comparing the newly determined sequences with previously sequenced genes from other organisms, scientists can predict likely functions for about half of the genes. The other half have no counterparts among previously sequenced microbial DNA and may be unique to M. tb and its close relatives. Those 2,000 or so genes are now the subjects of intense scrutiny. Some must be responsible for M. tb's ability to evade the immune system, while others may give the organism its virulence. Still others probably code for proteins that help build M. tb's uniquely tough cell wall.

The wealth of information flowing from the genome sequencing projects electrified every aspect of TB research. With a host of new techniques, scientists are now able to gain their clearest view yet of this remarkable, and deadly, microbe.

References

Cole, S. T. et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

Related Links

Non-government

back to top


Highlights

March 24, 2007
Statement of Christine F. Sizemore, Ph.D., Barbara E. Laughon, Ph.D., and Anthony S. Fauci, M.D. on World TB Day

Sept. 12, 2006
Statement: Successful Public-Private Partnership Between NIAID and Sequella Yields Promising New TB Drug for Clinical Testing

E-mail Icon E-mail this page
Print Icon Print this page
Plug-ins and Viewers
To open PDFs on this page, download and install the Adobe Acrobat Reader.

Highlights

March 24, 2007
Statement of Christine F. Sizemore, Ph.D., Barbara E. Laughon, Ph.D., and Anthony S. Fauci, M.D. on World TB Day

Sept. 12, 2006
Statement: Successful Public-Private Partnership Between NIAID and Sequella Yields Promising New TB Drug for Clinical Testing